BioSpace News Archive

Mesoblast Limited announced that the independent Data Safety Monitoring Board recommended continuation of the Phase 3 trial of remestemcel-L in patients with moderate to severe acute respiratory distress syndrome due to COVID-19 infection, following completion of trial’s first interim analysis.

Alligator Bioscience announced biomarker data from a recently performed clinical Phase I study of the drug candidate mitazalimab, its wholly owned CD40 antibody in development primarily for the treatment of pancreatic cancer.

RhoVac AB (“RhoVac”) announces today September 4 th 2020, that it is continuing to strengthen the Scientific Advisory Board with a pediatric immunologist, by appointing Professor Georg Holländer , Action Research Professor and Head of Department at Oxford University , UK and Professor in Development Immunology, ETH Zurich, Sw

Merck, known as MSD outside the United States and Canada, announced that Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories, is scheduled to participate in a fireside chat at the Citi 15th Annual BioPharma Virtual Conference on Sept. 10, 2020, at 8:00 a.m. EDT.

NeuroMetrix, Inc. reported that it will present a scientific poster at the PAINWeek 2020 Live Virtual Conference to be held September 11 - 13. PAINWeek is the preferred resource in the U.S. for frontline practitioners treating acute and chronic pain.

AVROBIO, Inc., a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, announced that the company has granted a non-statutory stock option for the purchase of up to 63,000 shares of the company’s common stock to one new employee as an inducement award under the company’s 2019 Inducement Plan, in accordance with Nasdaq Listing Rule 5635.

Castle Biosciences, Inc., a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, announced that Derek Maetzold, president and chief executive officer, is scheduled to present a company overview at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020, at 9:05 a.m. Eastern time.

Rocket Pharmaceuticals, Inc., a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces participation at the following upcoming conferences:

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that a presentation on the company’s orally administered, small molecule adrenocorticotropic hormone (ACTH) antagonist was selected for a late-breaking session at the virtual European Congress of Endocrinolog

Novocure (NASDAQ: NVCR) announced today that William Doyle, the company’s Executive Chairman, and Dr. Uri Weinberg, the company’s Chief Science Officer, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9, 2020. Mr. Doyle and Dr. Weinberg will take part in a fireside chat at 8:40 a.m. EDT. Mr. Doyle and Dr. Weinberg will also participate in one-on-one meetings with investors throughou